320 related articles for article (PubMed ID: 12605642)
1. H-caldesmon expression in myofibroblastoma of the breast: evidence supporting the distinction from leiomyoma.
Magro G; Gurrera A; Bisceglia M
Histopathology; 2003 Mar; 42(3):233-8. PubMed ID: 12605642
[TBL] [Abstract][Full Text] [Related]
2. Mammary myofibroblastoma with leiomyomatous differentiation: case report and literature review.
Mnif H; Charfi S; Abid N; Sallemi-Boudawara T
Pathologica; 2013 Aug; 105(4):142-5. PubMed ID: 24466766
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue.
Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S
Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the leiomyomatous variant of myofibroblastoma: a rare subset distinct from other smooth muscle tumors of the breast.
D'Alfonso TM; Subramaniyam S; Ginter PS; Mosquera JM; MacDonald TY; Noorzad Z; Orta LY; Liu YF; Rubin MA; Shin SJ
Hum Pathol; 2016 Dec; 58():54-61. PubMed ID: 27498061
[TBL] [Abstract][Full Text] [Related]
5. Mammary myofibroblastoma: a clinico- pathologic study of six cases.
Zahid MF; Zafar I; Din NU; Ahmed A; Fatima S; Kayani N
Breast Dis; 2015; 35(2):143-8. PubMed ID: 25547163
[TBL] [Abstract][Full Text] [Related]
6. Endometrial stromal neoplasms are immunoreactive with WT-1 antibody.
Sumathi VP; Al-Hussaini M; Connolly LE; Fullerton L; McCluggage WG
Int J Gynecol Pathol; 2004 Jul; 23(3):241-7. PubMed ID: 15213600
[TBL] [Abstract][Full Text] [Related]
7. Spindle cell lipoma-like tumor, solitary fibrous tumor and myofibroblastoma of the breast: a clinico-pathological analysis of 13 cases in favor of a unifying histogenetic concept.
Magro G; Bisceglia M; Michal M; Eusebi V
Virchows Arch; 2002 Mar; 440(3):249-60. PubMed ID: 11889594
[TBL] [Abstract][Full Text] [Related]
8. Expression of steroid hormone receptors, their regulated proteins, and bcl-2 protein in myofibroblastoma of the breast.
Magro G; Bisceglia M; Michal M
Histopathology; 2000 Jun; 36(6):515-21. PubMed ID: 10849093
[TBL] [Abstract][Full Text] [Related]
9. Mammary myofibroblastoma with leiomyomatous differentiation.
Thomas TM; Myint A; Mak CK; Chan JK
Am J Clin Pathol; 1997 Jan; 107(1):52-5. PubMed ID: 8980367
[TBL] [Abstract][Full Text] [Related]
10. Specific but variable expression of h-caldesmon in leiomyosarcomas: an immunohistochemical reassessment of a novel myogenic marker.
Hisaoka M; Wei-Qi S; Jian W; Morio T; Hashimoto H
Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):302-8. PubMed ID: 11759055
[TBL] [Abstract][Full Text] [Related]
11. Benign Fibromyxoid Lesion of the Breast: A Distinct Entity From Benign Spindle Cell Tumors of the Mammary Stroma?
Schwartz CJ; Schandl CA; Morse J; Ralston J; Rapkiewicz A; Darvishian F
Int J Surg Pathol; 2018 Sep; 26(6):488-493. PubMed ID: 29552929
[TBL] [Abstract][Full Text] [Related]
12. Breast tumors with myofibroblastic differentiation: clinico-pathological observations in myofibroblastoma and myofibrosarcoma.
Gocht A; Bösmüller HC; Bässler R; Tavassoli FA; Moinfar F; Katenkamp D; Schirrmacher K; Lüders P; Saeger W
Pathol Res Pract; 1999; 195(1):1-10. PubMed ID: 10048088
[TBL] [Abstract][Full Text] [Related]
13. [Mammary myofibroblastoma: a clinicopathologic analysis of nine cases].
Yu BH; Bai QM; Xu XL; Yang WT; Wang J
Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):747-752. PubMed ID: 30317728
[No Abstract] [Full Text] [Related]
14. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors.
Nucci MR; O'Connell JT; Huettner PC; Cviko A; Sun D; Quade BJ
Am J Surg Pathol; 2001 Apr; 25(4):455-63. PubMed ID: 11257619
[TBL] [Abstract][Full Text] [Related]
15. Palisaded myofibroblastoma of the breast: a tumor closely mimicking schwannoma: Report of 2 cases.
Magro G; Foschini MP; Eusebi V
Hum Pathol; 2013 Sep; 44(9):1941-6. PubMed ID: 23574785
[TBL] [Abstract][Full Text] [Related]
16. Fine-needle aspiration cytologic study of myofibroblastoma of the breast. Immunohistochemical and ultrastructural findings.
Amin MB; Gottlieb CA; Fitzmaurice M; Gaba AR; Lee MW; Zarbo RJ
Am J Clin Pathol; 1993 May; 99(5):593-7. PubMed ID: 8388162
[TBL] [Abstract][Full Text] [Related]
17. Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study.
Ceballos KM; Nielsen GP; Selig MK; O'Connell JX
Am J Clin Pathol; 2000 Nov; 114(5):746-53. PubMed ID: 11068549
[TBL] [Abstract][Full Text] [Related]
18. Mammary-type Myofibroblastoma with Leiomyomatous Differentiation: A Rare Variant with Potential Pitfalls.
Strait AM; Bridge JA; Iafrate AJ; Li MM; Xu F; Tsongalis GJ; Linos K
Int J Surg Pathol; 2022 Apr; 30(2):200-206. PubMed ID: 34338561
[TBL] [Abstract][Full Text] [Related]
19. Myofibroblastoma of breast: evidence favoring smooth-muscle rather than myofibroblastic differentiation.
Eyden BP; Shanks JH; Ioachim E; Ali HH; Christensen L; Howat AJ
Ultrastruct Pathol; 1999; 23(4):249-57. PubMed ID: 10503744
[TBL] [Abstract][Full Text] [Related]
20. Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation.
Miettinen MM; Sarlomo-Rikala M; Kovatich AJ; Lasota J
Mod Pathol; 1999 Aug; 12(8):756-62. PubMed ID: 10463476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
